Catalyst Wire Dossier Catalyst Wire Dossier

Losartan potassium and hydrochlorothiazide

losartan potassium and hydrochlorothiazide · Jubilant Cadista Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

65 regulatory and trial events tracked for Losartan potassium and hydrochlorothiazide, covering 2010-04-06 to 2026-02-17. Get the full timeline:

Most recent: FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

See pricing